Skip to content

Efficacy Verification of an Intelligent Decision Support System-Assisted Intervention Program for Sarcopenia in Community-Dwelling Older Adults

Development and Validation of an Intelligent Decision Support System for Sarcopenia in Community-Dwelling Older Adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120076
Enrollment
Unknown
Registered
2026-03-09
Start date
2024-12-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Intervention group:A Sarcopenia Intervention Program for Older Adults Supported by an Intelligent Decision Support System
Control group:Health Education and Usual Chronic Disease Care

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for sarcopenia according to AWGS 2019; 2. Age >= 60 years; 3. Expected to reside in the community for >= 3 months; 4. Able to communicate normally and possess basic literacy skills; 5. Provide informed consent; 6. Capable of using a smartphone to access WeChat messages.

Exclusion criteria

Exclusion criteria: 1. Have obvious disabilities preventing grip strength or gait speed tests; 2. Contraindications for bioelectrical impedance analysis (BIA) testing, such as having a cardiac stent, pacemaker, metal implants (e.g., screws, plates), or artificial joint replacements; 3. Chronic cardiac insufficiency; 4. Severe cognitive impairment or history of psychiatric disorders; 5. Acute exacerbation or end-stage of chronic diseases; 6. Conditions affecting mobility, such as Parkinson’s disease, motor neuron disease, or post-stroke status; 7. Currently participating in other clinical trials or dietary and/or exercise intervention programs; 8. Unhealed fractures; 9. Severe systemic or bilateral lower limb edema.

Design outcomes

Primary

MeasureTime frame
appendicular skeletal muscle;appendicular skeletal muscle mass index;handgrip strength;6-meter gait speed ;five chair stand time;

Secondary

MeasureTime frame
Nutritional Status;Activities of Daily Living;Depression;Anxiety;Self-Efficacy;Quality of Life;Skeletal Muscle Mass;Fat-free mass;

Countries

China

Contacts

Public ContactZhang Meng

West China Hospital, Sichuan University

hxmengzhang@163.com+86 187 0289 6831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026